wang, L. (2025). Clinical Progress of Targeted KRAS Drugs Combined with Immune Checkpoint Inhibitors in the Treatment of Pancreatic Cancer. Transactions on Materials, Biotechnology and Life Sciences, 8, 397-402. https://doi.org/10.62051/rq7x6r98